Biodegradable Polymers as Drug Delivery Systems for Bone Regeneration

Regenerative medicine has been widely researched for the treatment of bone defects. In the field of bone regenerative medicine, signaling molecules and the use of scaffolds are of particular importance as drug delivery systems (DDS) or carriers for cell differentiation, and various materials have be...

Full description

Saved in:
Bibliographic Details
Main Authors: Kaoru Aoki (Author), Naoto Saito (Author)
Format: Book
Published: MDPI AG, 2020-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_9f75c271f58c4ea9b47dba891aa5d80e
042 |a dc 
100 1 0 |a Kaoru Aoki  |e author 
700 1 0 |a Naoto Saito  |e author 
245 0 0 |a Biodegradable Polymers as Drug Delivery Systems for Bone Regeneration 
260 |b MDPI AG,   |c 2020-01-01T00:00:00Z. 
500 |a 1999-4923 
500 |a 10.3390/pharmaceutics12020095 
520 |a Regenerative medicine has been widely researched for the treatment of bone defects. In the field of bone regenerative medicine, signaling molecules and the use of scaffolds are of particular importance as drug delivery systems (DDS) or carriers for cell differentiation, and various materials have been explored for their potential use. Although calcium phosphates such as hydroxyapatite and tricalcium phosphate are clinically used as synthetic scaffold material for bone regeneration, biodegradable materials have attracted much attention in recent years for their clinical application as scaffolds due their ability to facilitate rapid localized absorption and replacement with autologous bone. In this review, we introduce the types, features, and performance characteristics of biodegradable polymer scaffolds in their role as DDS for bone regeneration therapy. 
546 |a EN 
690 |a biodegradable polymer 
690 |a drug delivery system 
690 |a bone regeneration 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 12, Iss 2, p 95 (2020) 
787 0 |n https://www.mdpi.com/1999-4923/12/2/95 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/9f75c271f58c4ea9b47dba891aa5d80e  |z Connect to this object online.